Wilson Sonsini Goodrich & Rosati advised IGM on the transaction.IGM Biosciences, Inc. announced the pricing of its underwritten public offering of 8,695,653 shares of its non-voting…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now